Pancreatic Cancer Research

ResearcherSaint Joseph UniversityActive in the last 2 years

Tarek Assi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5579-5264; OpenAlex author ID A5066080117. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 5

  1. Selpercatinib for RET-positive advanced pancreatic cancer detected by liquid biopsy: a case-based insight. Co-author DOI 10.1080/14622416.2025.2602419↗
  2. KRAS G12C mutation: from black sheep to key player in pancreatic cancer treatment Co-author DOI 10.2217/fon-2023-0067↗
  3. NALIRIFOX in the upfront setting of metastatic pancreatic cancer: can FOLFIRINOX finally be dethroned? Last author DOI 10.2217/fon-2023-0088↗
  4. Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospe… First author DOI 10.1016/j.clinre.2016.11.012↗
  5. Dilemma of first line regimens in metastatic pancreatic adenocarcinoma. Co-author DOI 10.3748/wjg.v22.i46.10124↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Axel Le Cesne · 3 shared papers, 2023–2025 · strength 0.78
  2. Rebecca Ibrahim · 2 shared papers, 2023 · strength 0.48
  3. Rita Khoury · 2 shared papers, 2023 · strength 0.48
  4. Elie Rassy · 2 shared papers, 2016–2017 · strength 0.16
  5. Marwan G. Ghosn · 2 shared papers, 2016–2017 · strength 0.16
  6. Joseph Gergi Kattan · 2 shared papers, 2016–2017 · strength 0.16
  7. Hampig Raphaël Kourié · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.